Allergan plc AGN
No live quote for AGN yet.
Analyst view
Consensus: hold
Hold
Price target (mean) 188.33
- Target (low)
- 157.00
- Target (mean)
- 188.33
- Target (high)
- 203.00
Ratings (0m) 21 13 buy · 8 hold · 0 sell
- Strong buy4
- Buy9
- Hold8
- Sell0
- Strong sell0
Recommendation trend
- This month 21
- 1 month ago 17
- 2 months ago 17
- 3 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 3.97 | 3.61 – 4.24 | 3.79 | +4.7% | 0 | 0.0% | 7 |
| Next quarter | 3.58 | 2.30 – 4.49 | 4.38 | -18.3% | 3.60B | -12.0% | 7 |
| Current year | 16.11 | 13.16 – 17.85 | 17.64 | -8.7% | 15.36B | -4.4% | 13 |
| Next year | 17.74 | 15.10 – 19.31 | 16.11 | +10.1% | 16.12B | +4.9% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 21, 2020 | SunTrust Robinson Humphrey | Downgrade | Buy | Hold |
| Mar 25, 2020 | CFRA | Downgrade | Buy | Hold |
| Feb 11, 2020 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| Jan 22, 2020 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Nov 19, 2019 | UBS | Downgrade | Buy | Neutral |
| Sep 12, 2019 | UBS | Maintained | — | Buy |
| Aug 7, 2019 | Guggenheim | Downgrade | Buy | Neutral |
| Jul 18, 2019 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Jul 16, 2019 | Bernstein | Downgrade | Outperform | Market Perform |
| Jun 26, 2019 | Mizuho | Downgrade | Buy | Neutral |
| Jun 25, 2019 | Mizuho | Maintained | — | Buy |
| May 9, 2019 | Raymond James | Maintained | — | Outperform |
| May 9, 2019 | UBS | Maintained | — | Buy |
| May 8, 2019 | RBC Capital | Maintained | — | Sector Perform |
| May 8, 2019 | Wells Fargo | Maintained | — | Outperform |
| Apr 3, 2019 | UBS | Maintained | Buy | Buy |
| Mar 7, 2019 | Credit Suisse | Maintained | Neutral | Neutral |
| Feb 13, 2019 | Wells Fargo | Maintained | Outperform | Outperform |
| Jan 31, 2019 | Credit Suisse | Downgrade | Outperform | Neutral |
| Jan 30, 2019 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jan 30, 2019 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Jan 8, 2019 | Credit Suisse | Maintained | Outperform | Outperform |
| Oct 31, 2018 | Credit Suisse | Maintained | Outperform | Outperform |
| Oct 31, 2018 | Raymond James | Maintained | Outperform | Outperform |
| Sep 17, 2018 | Raymond James | Maintained | Outperform | Outperform |
| Aug 23, 2018 | Wells Fargo | Maintained | Outperform | Outperform |
| Aug 23, 2018 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 12, 2018 | Bank of America | Maintained | Buy | Buy |
| Jun 11, 2018 | Mizuho | Maintained | Neutral | Neutral |
| May 5, 2018 | Argus | Downgrade | Buy | Hold |